Press releases

Genesis 2010, Westminster, Thursday 9 December is on track to attract a larger than ever attendance to debate new medicines and healthcare products research. More

Cambridge, 4 November 2010 - One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is to launch a series of high level conferences focused on specific technology areas, replacing its annual BioPartneri More

The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More

New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More

Pharmalicensing now offers in-depth and involved consulting to guide you through the process of licensing More

With deals increasing in terms of number and value, partnering at early stage development is now an integral component of pharmaceutical and biotech business strategy. Pharmalicensing has revised and updated its successful Early Stage report More

Canada's lacklustre pace in adopting health innovations and commercializing new products and processes is costing our health system, according to organizers of a Richard Ivey School of Business conference taking place next week. More

New agreement in Animal Health area More

Agreement between Medincell and Novartis Animal Health More